Olema Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hi. Good afternoon, everybody, and thank you for joining day three of the Morgan Stanley Global Healthcare Conference Monday afternoon. And with me, I have Olema and Sean Bohen, CEO. I'm going to read a quick disclaimer, and then we'll get started. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So Sean, thank you for joining, and to the audience, thank you for attending this fireside chat. I am Albert Hwang, Managing Director, Co-Head of the US healthcare group here in the investment banking division. Maybe what we'll do is kick it off with Sean. If you can just give a quick overview of Olema and a quick update of where you stand in clinical trials, we can get into the questions.
Okay, great. Sure. Thank you, Albert, for hosting. Olema is the way we pronounce it. And thanks, everyone,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
